Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2
Article
Karuppaiah, G, Vashist, A, Nair, M et al. (2023). Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2
. 13 10.1016/j.biosx.2023.100324
Karuppaiah, G, Vashist, A, Nair, M et al. (2023). Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2
. 13 10.1016/j.biosx.2023.100324
COVID-19, a highly contagious viral infection caused by the occurrence of severe acute respiratory syndrome coronavirus (SARS-CoV-2), has turned out to be a viral pandemic then ravaged many countries worldwide. In the recent years, point-of-care (POC) biosensors combined with state-of-the-art bioreceptors, and transducing systems enabled the development of novel diagnostic tools for rapid and reliable detection of biomarkers associated with SARS-CoV-2. The present review thoroughly summarises and discusses various biosensing strategies developed for probing SARS-CoV-2 molecular architectures (viral genome, S Protein, M protein, E protein, N protein and non-structural proteins) and antibodies as a potential diagnostic tool for COVID-19. This review discusses the various structural components of SARS-CoV-2, their binding regions and the bioreceptors used for recognizing the structural components. The various types of clinical specimens investigated for rapid and POC detection of SARS-CoV-2 is also highlighted. The importance of nanotechnology and artificial intelligence (AI) approaches in improving the biosensor performance for real-time and reagent-free monitoring the biomarkers of SARS-CoV-2 is also summarized. This review also encompasses existing practical challenges and prospects for developing new POC biosensors for clinical monitoring of COVID-19.
